☰

Xinyuan Wu, Ph.D. - Publications

Affiliations: 
2003 Stony Brook University, Stony Brook, NY, United States 
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Hu K, Zhang Y, Wu X, Jin X, Mao S, Ding P, Wu S, Ren J. Lupiwighteone as an Antitumor Agent Reverses Multidrug Resistance in K562/ADR Cells by Regulating Cellular Prion Protein-Oct4 Axis. Anti-Cancer Agents in Medicinal Chemistry. PMID 39129165 DOI: 10.2174/0118715206316284240807100226  0.302
2016 Dong M, Wang HY, Zhao XX, Chen JN, Zhang YW, Huang Y, Xue L, Li HG, Du H, Wu XY, Shao CK. Expression and prognostic roles of PIK3CA, JAK2, PD-L1 and PD-L2 in EBV-associated gastric carcinoma. Human Pathology. PMID 26980034 DOI: 10.1016/j.humpath.2016.02.007  0.431
2009 Pepe A, Sun L, Zanardi I, Wu X, Ferlini C, Fontana G, Bombardelli E, Ojima I. Novel C-seco-taxoids possessing high potency against paclitaxel-resistant cancer cell lines overexpressing class III beta-tubulin. Bioorganic & Medicinal Chemistry Letters. 19: 3300-4. PMID 19423340 DOI: 10.1016/J.Bmcl.2009.04.070  0.629
2009 Pepe A, Sun L, Zanardi I, Wu X, Ferlini C, Fontana G, Bombardelli E, Ojima I. ChemInform Abstract: Novel C-Seco-Taxoids Possessing High Potency Against Paclitaxel-Resistant Cancer Cell Lines Overexpressing Class III β-Tubulin. Cheminform. 40. DOI: 10.1002/chin.200944181  0.621
2006 Kuznetsova L, Chen J, Sun L, Wu X, Pepe A, Veith JM, Pera P, Bernacki RJ, Ojima I. Syntheses and evaluation of novel fatty acid-second-generation taxoid conjugates as promising anticancer agents. Bioorganic & Medicinal Chemistry Letters. 16: 974-7. PMID 16298526 DOI: 10.1016/J.Bmcl.2005.10.089  0.675
2005 Ojima I, Borella CP, Wu X, Bounaud PY, Oderda CF, Sturm M, Miller ML, Chakravarty S, Chen J, Huang Q, Pera P, Brooks TA, Baer MR, Bernacki RJ. Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents. Journal of Medicinal Chemistry. 48: 2218-28. PMID 15771464 DOI: 10.1021/Jm049483Y  0.617
2004 Miller ML, Roller EE, Wu X, Leece BA, Goldmacher VS, Chari RV, Ojima I. Synthesis of potent taxoids for tumor-specific delivery using monoclonal antibodies. Bioorganic & Medicinal Chemistry Letters. 14: 4079-82. PMID 15225730 DOI: 10.1016/J.Bmcl.2004.05.027  0.466
2004 Wu X, Ojima I. Tumor specific novel taxoid-monoclonal antibody conjugates. Current Medicinal Chemistry. 11: 429-38. PMID 14965224 DOI: 10.2174/0929867043455963  0.54
2004 Kuznetsova L, Ungureanu IM, Pepe A, Zanardi I, Wu X, Ojima I. Trifluoromethyl- and difluoromethyl-β-lactams as useful building blocks for the synthesis of fluorinated amino acids, dipeptides, and fluoro-taxoids Journal of Fluorine Chemistry. 125: 487-500. DOI: 10.1016/J.Jfluchem.2003.12.001  0.623
2002 Ojima I, Geng X, Wu X, Qu C, Borella CP, Xie H, Wilhelm SD, Leece BA, Bartle LM, Goldmacher VS, Chari RV. Tumor-specific novel taxoid-monoclonal antibody conjugates. Journal of Medicinal Chemistry. 45: 5620-3. PMID 12477344 DOI: 10.1021/Jm025540G  0.579
Show low-probability matches.